Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2003
08/12/2003CA2348132C A system for cell-based screening
08/12/2003CA2264441C Methods for determining the biocompability of lipophilic substances in cell culture tests using nanoemulsions
08/11/2003CA2418399A1 Non-invasive system for the determination of analytes in body fluids
08/07/2003WO2003065282A1 Computer systems and methods for identifying genes and determining pathways associated with traits
08/07/2003WO2003065281A1 Statistical algorithms for folding and target accessibility prediction and design of nucleic acids
08/07/2003WO2003065146A2 Methods for placing, accepting, and filling orders for products and services
08/07/2003WO2003065058A1 Circuit arrangement, redox recycling sensor, sensor assembly and a method for processing a current signal provided by a sensor electrode
08/07/2003WO2003065047A1 Device for automatic analysis of a liquid sample
08/07/2003WO2003065046A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
08/07/2003WO2003065045A2 Diagnostics and therapeutics for diseases associated with the gpr65 receptor
08/07/2003WO2003065044A2 Diagnostics and therapeutics for diseases associated with gpr72
08/07/2003WO2003065043A2 Identification and relative quantification of proteins
08/07/2003WO2003065042A1 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
08/07/2003WO2003065041A1 A label-free high throughput optical technique for detecting biomolecular interactions.
08/07/2003WO2003065040A1 Method of fixing biomolecule to carrier
08/07/2003WO2003065039A1 Specimen analysis disk and specimen analysis device
08/07/2003WO2003065036A1 Method of identifying insulin secretion stimulating compounds, and the use of such compounds in treating insulin-secretion related disorders
08/07/2003WO2003065035A1 Method for monitoring and prognosis of disease course of gastrointestinal tumors
08/07/2003WO2003065034A1 Gene discovery for the system assignment of gene function
08/07/2003WO2003065032A2 System and method for preventing fouling in sensors
08/07/2003WO2003065027A1 Sensor field for measuring humidity and a method for producing the same
08/07/2003WO2003065017A2 A method and device to ascertain physical characteristics of porous media
08/07/2003WO2003065016A1 Particle quantifying apparatus and method
08/07/2003WO2003065012A2 Compositions and methods for reporting of protease activity within the secretory pathway
08/07/2003WO2003065009A2 Methods and apparatus for assays of bacterial spores
08/07/2003WO2003065008A2 Methods and compositions for identification and therapeutic use of genes involved in vascular and proliferative diseases
08/07/2003WO2003065007A2 Sample level detection system
08/07/2003WO2003065006A2 Methods and compositions for treating cancer
08/07/2003WO2003065003A2 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
08/07/2003WO2003065002A2 Rapid lateral flow assay for determining exposure to mycobacterium tuberculosis and other mycobacteria
08/07/2003WO2003064999A2 Methods for identifying modulators of receptor tyrosine kinases
08/07/2003WO2003064997A2 Microarrays produced by cross-sectioning multi-sample plates
08/07/2003WO2003064996A2 Bio-safe dispenser and optical analysis disc assembly
08/07/2003WO2003064995A2 A guided mode resonant filter biosensor using a linear grating surface structure
08/07/2003WO2003064994A2 Methods of collecting and analyzing human breath
08/07/2003WO2003064991A2 Method and apparatus using a nonlinear optical technique for detection of probe-target interactions in a field
08/07/2003WO2003064714A1 A method and a device for thermal analysis of cast iron
08/07/2003WO2003064704A1 Chemical proteomics
08/07/2003WO2003064693A1 Mart-1 compounds for therapy and diagnosis and methods for using same
08/07/2003WO2003064690A2 Process for detecting predisposition to a cardiovascular disease
08/07/2003WO2003064687A2 Prognostic and treatment methods relating to fibrotic liver disease
08/07/2003WO2003064686A1 Method and test kit for demonstrating genetic identity
08/07/2003WO2003064685A2 Genetic polymorphisms in the preprotachykinin gene
08/07/2003WO2003064683A1 Method of quantifying glycosylated protein using redox reaction and quantification kit
08/07/2003WO2003064682A1 Cancer monitoring by aberrant promotor methylation of the transcription factor genes pax5 alpha pax5 beta, novel loop helix loop protein, novel gene 2, and beta3 genes
08/07/2003WO2003064681A2 Assays
08/07/2003WO2003064675A2 Rapid methods and devices for the detection of coliform and the detection and confirmation of e. coli
08/07/2003WO2003064663A1 Polymorphisms in elastin, fibrillin, and related genes as predisposing to restenosis and to atherosclerosis
08/07/2003WO2003064656A1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
08/07/2003WO2003064645A1 Novel n-acetylgalactosamine transferase and nucleic acid encoding the same
08/07/2003WO2003064629A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/07/2003WO2003064624A2 Molecular hepatotoxicology modeling
08/07/2003WO2003064620A2 Hepsin substrates and prodrugs
08/07/2003WO2003064613A2 Amidases, nucleic acids encoding them and methods for making and using them
08/07/2003WO2003064604A2 Translation profiling
08/07/2003WO2003064593A2 Antigen panels and methods of using the same
08/07/2003WO2003064592A2 Inhibitors of autoinducer transporters
08/07/2003WO2003064588A2 Structural basis of quorum sensing signal generation and methods and therapeutic agents derived therefrom
08/07/2003WO2003064473A2 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity
08/07/2003WO2003064472A2 Treatment of ms with goat serum
08/07/2003WO2003064471A2 Gene for peripheral arterial occlusive disease
08/07/2003WO2003064468A2 The ligand binding pocket peptide fragment of estrogen-related receptor 3 (err3), its crystal structure, and uses thereof
08/07/2003WO2003064467A1 A complex of a human foxc2 protein and a foxc2-interacting protein
08/07/2003WO2003064466A1 Variants of the alpha 1 subunit of human ampk
08/07/2003WO2003064463A2 Pluripotency determining factors and uses thereof
08/07/2003WO2003064460A2 Two gonadotropin releasing hormones and a method to isolate the same
08/07/2003WO2003064451A2 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
08/07/2003WO2003064434A1 Electrochemical saccharide sensor
08/07/2003WO2003064391A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid
08/07/2003WO2003064325A1 Method for determining the dissolution rate of a solid water treatment product
08/07/2003WO2003063929A1 Peritoneal dialysis system
08/07/2003WO2003063907A1 Drugs ameliorating circadian rhythum disorder
08/07/2003WO2003063893A2 Fgfr agonists
08/07/2003WO2003063891A1 Compositions and methods for modulating connexin hemichannels
08/07/2003WO2003063880A1 Disruption of islet amyloid by polycyclic compounds
08/07/2003WO2003063798A2 Compositions and methods for treatment of infectious and inflammatory diseases
08/07/2003WO2003063784A2 MOLECULES THAT MODULATE GαQ ACTIVITY AND METHODS OF TREATING URINARY INCONTINENCE
08/07/2003WO2003063783A2 Multiple virus replicon culture systems
08/07/2003WO2003063782A2 Kappa-pviia-related conotoxins as organ protectants
08/07/2003WO2003063777A2 Rapid phenotypic cell-based hiv assay
08/07/2003WO2003063770A2 Expression vectors encoding epitopes of target-associated antigens and methods for their design
08/07/2003WO2003063763A2 Complement mediated assays for in vivo and in vitro methods
08/07/2003WO2003063759A2 Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
08/07/2003WO2003063693A2 Method for detecting microorganisms
08/07/2003WO2003063690A2 Secreted caveolin as a marker for prostate cancer
08/07/2003WO2003063689A2 Islr gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
08/07/2003WO2003063679A2 Hepatitis e virus clones and methods of their use
08/07/2003WO2003046582A8 CANCER PROGNOSIS USING THYMOSIN β10 (Tβ10)
08/07/2003WO2003046556A3 Globin biopolymer markers indicative of insulin resistance
08/07/2003WO2003046202A3 Assaying apparatus, kit, and method for lipids and associated enzymes
08/07/2003WO2003042654A9 Multi-parameter high throughput screening assays (mphts)
08/07/2003WO2003042366A3 A novel saitohin gene and uses of same
08/07/2003WO2003036225A9 Method for biomolecular sensing and system thereof
08/07/2003WO2003030616A3 21132, a human g-protein coupled receptor family member and uses therefor
08/07/2003WO2003019190A8 Method for detecting in/vitro food antigen intolerance
08/07/2003WO2003018797A3 Method and device for integrated protein expression, purification and detection
08/07/2003WO2003016516A3 Kinase crystal structures and materials and methods for kinase activation
08/07/2003WO2003014695A3 Biosensor and method for detecting macromolecular biopolymers by means of at least one unit for immobilizing macromolecular biopolymers
08/07/2003WO2003012447A3 Identification of living microorganisms, eukaryotic cells or organelles
08/07/2003WO2003008640A3 Asthma-associated gene
1 ... 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 ... 3937